One Innovation, Many Stakeholders. From Health Research to Market Adoption.

Bringing a health innovation to market in Europe requires far more than scientific excellence. Investors want to understand the business opportunity. Regulators expect robust evidence and compliance. Payers need proof of value. Healthcare professionals, patients and the public must trust and adopt the solution. A promising innovation can therefore face multiple decision-makers, each asking a different question: 🔹 Is this worth investing in? 🔹 Is it valid, safe and compliant? 🔹 Is it worth paying for? 🔹 Will people trust it and use it? This event brings together experts from medical research, entrepreneurship, legal & regulatory affairs, healthcare policy, reimbursement and market access to explore how innovators can successfully navigate these interconnected stakeholder expectations and transform health research into real-world impact. What we will discuss Investors & Strategic Partners Understanding what makes a health innovation investable, including business models, regulatory strategy and intellectual property considerations. Regulators Building evidence, navigating EU regulatory frameworks, addressing data governance and AI requirements, and avoiding common compliance pitfalls. Payers Designing evidence for reimbursement, understanding HTA requirements, and developing successful market access strategies across Europe. Healthcare Professionals, Patients & Society Creating trust, demonstrating meaningful value, communicating responsibly, and supporting adoption beyond regulatory approval. Who should attend? • HealthTech, MedTech and Biotech founders and executives • Researchers and innovators • Investors and innovation support organisations • Healthcare industry representatives • Technology transfer and innovation managers Join us for an interdisciplinary discussion on what it really takes to move from health research to market adoption in today's European healthcare landscape.